Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline Texas Instruments Incorporated TXN Analysts Raise Price Targets Following Strong Q1 2026 Performance and Upbeat Forward Guidance What capacity utilization NextCure NXTC 247 20260427